| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |